From London Vision Clinic, London, United Kingdom (DZR, TJA); the Department of Ophthalmology, Columbia University Medical Center, New York, New York (DZR); Centre Hospitalier National d'Ophtalmologie, Paris, France (DZR); Biomedical Science Research Institute, University of Ulster, Coleraine, Northern Ireland (DZR, TJA); University Hospital Ayr, Ayr, Scotland, United Kingdom (SS); Intermountain Ocular Research Center and John Moran Eye Center, University of Utah, Salt Lake City, Utah (NM); the Department of Ophthalmology, Goethe-University, Frankfurt am Main, Germany (TK); Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio (WJD); Biomedical Engineering, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio (WJD); the Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio (WJD); the Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California (JBR); and University of Southern California Roski Eye Institute, Los Angeles, California (JBR).
Supported in part by an unrestricted departmental grant to the University of Southern California Roski Eye Institute Department of Ophthalmology from Research to Prevent Blindness, Inc., New York, New York (JBR) and NIH R01 EY023381 (WJD).
Dr. Reinstein is a consultant for Carl Zeiss Meditec (Jena, Germany), has a proprietary interest in the Artemis technology (ArcScan Inc., Morrison, Colorado), and is an author of patents related to VHF digital ultrasound administered by the Cornell Center for Technology Enterprise and Commercialization (CCTEC), Ithaca, New York. Dr. Mamalis is on the board of Anew Optics, Inc., and is a consultant for Medennium, Inc. Dr. Kohnen is a consultant for or on the advisory board of Abbott, Alcon, Geuder, Oculus, Santen, Schwind, Staar, TearLab, Thea Pharma, Thieme Compliance, Ziemer, and Zeiss and has received research funding from Abbott, Alcon, Hoya, Oculentis, Oculus, Schwind, and Zeiss. Dr. Dupps is a member of the medical advisory board of Avedro, has performed sponsored research for Carl Zeiss Meditec and Alcon (Fort Worth, Texas), and is an author of patents related to computational modeling of the eye and OCT elastography administered by Cleveland Clinic Innovation, Cleveland, Ohio, and licensed to OptoQuest, Inc., Cleveland, Ohio. The remaining authors have no proprietary or financial interest in the materials presented herein.
This editorial will also appear in the April 2017 issue of the Journal of Cataract & Refractive Surgery.
Correspondence: Dan Z. Reinstein, MD, MA(Cantab), FRCSC, London Vision Clinic, 138 Harley Street, London W1G 7LA, United Kingdom. E-mail: